Stable Isotope Labeled Compounds Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Stable Isotope Labeled Compounds Market is segmented by Type (Deuterium, Carbon-13, Oxygen-18, Other Stable Isotopes), Application, and Geography.

Stable Isotope Labeled Compounds Market Snapshot

Stable Isotope Labeled Compounds Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.3 %
Stable Isotope Labeled Compounds Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The  Stable Isotope Labeled Compounds market is projected to grow with a CAGR of nearly 3.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of cancer. According to the National Institutes of Health (NIH), in 2018, an estimated 1,735,350 new cases of cancer will be detected in the United States and 609,640 people will die from the disease. Furthermore, the growing investments in research and development programs by the biotechnology and pharmaceutical companies is boosting the market growth.  However, the high cost of the isotope compounds is the major drawback of the market.

Scope of the Report

As per the scope of the report, stable isotopes are non-radioactive forms of atoms. Although they do not emit radiation. This report is segmented by Type, by Application, and by Geography.

By Type
Deuterium
Carbon-13
Oxygen-18
Other Stable Isotopes
By Application
Research and Development
Clinical Diagnostics
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Research and Development Segment is Dominating the Stable Isotope Labeled Compounds Market.

The growth of the segment is attributed to the increase in research and development spending. Both government and major players are investing in product development. Stable isotope tracers can be safely governed simultaneously to the same subject without compromising future studies. The plasma volume which is needed from one sample to analyze the isotope enrichment is small, allowing even preterm infants to be studied. Extensive studies are going on for biological side effects and metabolic fate of the compound. The other factors that are boosting the market growth are the increasing incidence of cancer as these are majorly used in cancer diagnostics.

Stable Isotope Labeled Compounds Market Trends

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, the high prevalence of cancer in the region, established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.

Stable Isotope Labeled Compounds Market Growth

Competitive Landscape

The Stable Isotope Labeled Compounds market is moderately competitive and consists of several major players. Some of the international companies that are present in this market are PerkinElmer Inc, Merck KGaA, Cambridge Isotope Laboratories, Inc., JSC Isotope., Medical Isotopes, Inc., Omicron Biochemicals, Inc., Trace Sciences International, Alsachim, Taiyo Nippon Sanso Corporation.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Proteomics Research

      2. 4.2.2 Rising Prevalence of Cancer

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Labour

      2. 4.3.2 High Cost of Stable Isotope-Labeled Compounds

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Deuterium

      2. 5.1.2 Carbon-13

      3. 5.1.3 Oxygen-18

      4. 5.1.4 Other Stable Isotopes

    2. 5.2 By Application

      1. 5.2.1 Research and Development

      2. 5.2.2 Clinical Diagnostics

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 PerkinElmer Inc

      2. 6.1.2 Merck KGaA

      3. 6.1.3 Cambridge Isotope Laboratories, Inc.

      4. 6.1.4 JSC Isotope.

      5. 6.1.5 Medical Isotopes, Inc.

      6. 6.1.6 Omicron Biochemicals, Inc.

      7. 6.1.7 Trace Sciences International

      8. 6.1.8 Alsachim

      9. 6.1.9 Taiyo Nippon Sanso Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Stable Isotope Labeled Compounds Market market is studied from 2018 - 2026.

The Stable Isotope Labeled Compounds Market is growing at a CAGR of 3.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

PerkinElmer Inc, Merck KGaA, Cambridge Isotope Laboratories, Inc., JSC Isotope., Medical Isotopes, Inc. are the major companies operating in Stable Isotope Labeled Compounds Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!